Uranium
Compare Stocks
5 / 10Stock Comparison
URG vs GEV vs ETN vs UEC vs EMR
Revenue, margins, valuation, and 5-year total return — side by side.
Renewable Utilities
Industrial - Machinery
Uranium
Industrial - Machinery
URG vs GEV vs ETN vs UEC vs EMR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Uranium | Renewable Utilities | Industrial - Machinery | Uranium | Industrial - Machinery |
| Market Cap | $681M | $281.02B | $155.02B | $7.63B | $79.02B |
| Revenue (TTM) | $27M | $39.38B | $28.52B | $20M | $18.32B |
| Net Income (TTM) | $-75M | $9.38B | $3.99B | $-82M | $2.44B |
| Gross Margin | -65.2% | 19.9% | 36.9% | 28.3% | 52.7% |
| Operating Margin | -255.0% | 3.9% | 18.1% | -5.5% | 19.8% |
| Forward P/E | — | 37.6x | 30.0x | — | 21.7x |
| Total Debt | $68M | $0.00 | $11.17B | $2M | $13.76B |
| Cash & Equiv. | $124M | $8.85B | $622M | $149M | $1.54B |
URG vs GEV vs ETN vs UEC vs EMR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Mar 24 | May 26 | Return |
|---|---|---|---|
| Ur-Energy Inc. (URG) | 100 | 113.1 | +13.1% |
| GE Vernova Inc. (GEV) | 100 | 764.7 | +664.7% |
| Eaton Corporation p… (ETN) | 100 | 127.7 | +27.7% |
| Uranium Energy Corp. (UEC) | 100 | 231.0 | +131.0% |
| Emerson Electric Co. (EMR) | 100 | 124.4 | +24.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: URG vs GEV vs ETN vs UEC vs EMR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Among these 5 stocks, URG doesn't own a clear edge in any measured category.
GEV has the current edge in this matchup, primarily because of its strength in quality and efficiency.
- 23.8% margin vs UEC's -403.6%
- 15.2% ROA vs URG's -37.6%, ROIC 27.9% vs -130.4%
ETN is the clearest fit if your priority is sleep-well-at-night and valuation efficiency.
- Lower volatility, beta 1.42, Low D/E 57.4%, current ratio 1.32x
- PEG 1.22 vs EMR's 4.81
- Beta 1.42, yield 1.0%, current ratio 1.32x
- Beta 1.42 vs UEC's 1.79
UEC is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.
- Rev growth 297.4%, EPS growth -172.1%, 3Y rev CAGR 42.4%
- 19.8% 10Y total return vs GEV's 7.0%
- 297.4% revenue growth vs URG's -19.3%
- +170.2% vs EMR's +30.4%
EMR ranks third and is worth considering specifically for income & stability.
- Dividend streak 37 yrs, beta 1.52, yield 1.5%
- Better valuation composite
- 1.5% yield, 37-year raise streak, vs ETN's 1.0%, (2 stocks pay no dividend)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 297.4% revenue growth vs URG's -19.3% | |
| Value | Better valuation composite | |
| Quality / Margins | 23.8% margin vs UEC's -403.6% | |
| Stability / Safety | Beta 1.42 vs UEC's 1.79 | |
| Dividends | 1.5% yield, 37-year raise streak, vs ETN's 1.0%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +170.2% vs EMR's +30.4% | |
| Efficiency (ROA) | 15.2% ROA vs URG's -37.6%, ROIC 27.9% vs -130.4% |
URG vs GEV vs ETN vs UEC vs EMR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
URG vs GEV vs ETN vs UEC vs EMR — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
EMR leads in 3 of 6 categories
GEV leads 2 • ETN leads 1 • URG leads 0 • UEC leads 0
Explore the data ↓Income & Cash Flow (Last 12 Months)
EMR leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
GEV is the larger business by revenue, generating $39.4B annually — 1949.3x UEC's $20M. GEV is the more profitable business, keeping 23.8% of every revenue dollar as net income compared to UEC's -4.0%. On growth, ETN holds the edge at +16.8% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $27M | $39.4B | $28.5B | $20M | $18.3B |
| EBITDAEarnings before interest/tax | -$63M | $2.2B | $5.9B | -$104M | $4.7B |
| Net IncomeAfter-tax profit | -$75M | $9.4B | $4.0B | -$82M | $2.4B |
| Free Cash FlowCash after capex | -$67M | $3.6B | $4.7B | -$122M | $3.1B |
| Gross MarginGross profit ÷ Revenue | -65.2% | +19.9% | +36.9% | +28.3% | +52.7% |
| Operating MarginEBIT ÷ Revenue | -2.6% | +3.9% | +18.1% | -5.5% | +19.8% |
| Net MarginNet income ÷ Revenue | -2.8% | +23.8% | +14.0% | -4.0% | +13.3% |
| FCF MarginFCF ÷ Revenue | -2.4% | +9.2% | +16.5% | -6.0% | +17.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | -53.9% | +16.1% | +16.8% | -59.4% | +2.9% |
| EPS Growth (YoY)Latest quarter vs prior year | +25.2% | +18.2% | -9.4% | -19.0% | +28.2% |
Valuation Metrics
EMR leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 34.9x trailing earnings, EMR trades at a 41% valuation discount to GEV's 59.1x P/E. Adjusting for growth (PEG ratio), ETN offers better value at 1.55x vs EMR's 7.73x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $681M | $281.0B | $155.0B | $7.6B | $79.0B |
| Enterprise ValueMkt cap + debt − cash | $625M | $272.2B | $165.6B | $7.5B | $91.2B |
| Trailing P/EPrice ÷ TTM EPS | -9.05x | 59.12x | 38.17x | -77.95x | 34.92x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 37.62x | 30.00x | — | 21.71x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 1.55x | — | 7.73x |
| EV / EBITDAEnterprise value multiple | — | 121.45x | 27.69x | — | 18.07x |
| Price / SalesMarket cap ÷ Revenue | 25.03x | 7.38x | 5.65x | 114.12x | 4.39x |
| Price / BookPrice ÷ Book value/share | 8.61x | 23.47x | 7.99x | 6.78x | 3.94x |
| Price / FCFMarket cap ÷ FCF | — | 75.73x | 34.67x | — | 29.63x |
Profitability & Efficiency
GEV leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
GEV delivers a 79.7% return on equity — every $100 of shareholder capital generates $80 in annual profit, vs $-76 for URG. UEC carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to URG's 0.88x. On the Piotroski fundamental quality scale (0–9), EMR scores 7/9 vs URG's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -76.2% | +79.7% | +20.8% | -7.1% | +12.1% |
| ROA (TTM)Return on assets | -37.6% | +15.2% | +9.0% | -6.4% | +5.8% |
| ROICReturn on invested capital | -130.4% | +27.9% | +13.6% | -7.2% | +8.2% |
| ROCEReturn on capital employed | -33.1% | +6.6% | +16.8% | -7.6% | +10.0% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 6 | 6 | 5 | 7 |
| Debt / EquityFinancial leverage | 0.88x | — | 0.57x | 0.00x | 0.68x |
| Net DebtTotal debt minus cash | -$56M | -$8.8B | $10.5B | -$149M | $12.2B |
| Cash & Equiv.Liquid assets | $124M | $8.8B | $622M | $149M | $1.5B |
| Total DebtShort + long-term debt | $68M | $0 | $11.2B | $2M | $13.8B |
| Interest CoverageEBIT ÷ Interest expense | -39.41x | — | 16.38x | -185.47x | 6.46x |
Total Returns (Dividends Reinvested)
GEV leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in GEV five years ago would be worth $79,830 today (with dividends reinvested), compared to $12,929 for URG. Over the past 12 months, UEC leads with a +170.2% total return vs EMR's +30.4%. The 3-year compound annual growth rate (CAGR) favors GEV at 99.9% vs EMR's 20.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +18.3% | +54.0% | +22.3% | +18.9% | +4.3% |
| 1-Year ReturnPast 12 months | +160.3% | +157.4% | +33.2% | +170.2% | +30.4% |
| 3-Year ReturnCumulative with dividends | +91.7% | +698.3% | +141.3% | +490.5% | +75.9% |
| 5-Year ReturnCumulative with dividends | +29.3% | +698.3% | +182.8% | +366.8% | +59.5% |
| 10-Year ReturnCumulative with dividends | +258.8% | +698.3% | +608.7% | +1978.4% | +206.6% |
| CAGR (3Y)Annualised 3-year return | +24.2% | +99.9% | +34.1% | +80.8% | +20.7% |
Risk & Volatility
ETN leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
ETN is the less volatile stock with a 1.42 beta — it tends to amplify market swings less than UEC's 1.79 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ETN currently trades 91.7% from its 52-week high vs UEC's 76.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.52x | 1.76x | 1.42x | 1.79x | 1.52x |
| 52-Week HighHighest price in past year | $2.35 | $1181.95 | $435.43 | $20.34 | $165.15 |
| 52-Week LowLowest price in past year | $0.67 | $387.03 | $296.93 | $5.03 | $108.37 |
| % of 52W HighCurrent price vs 52-week peak | +77.0% | +88.5% | +91.7% | +76.6% | +85.4% |
| RSI (14)Momentum oscillator 0–100 | 62.9 | 66.5 | 59.8 | 58.1 | 61.3 |
| Avg Volume (50D)Average daily shares traded | 7.8M | 2.4M | 2.5M | 9.2M | 2.8M |
Analyst Outlook
EMR leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: URG as "Buy", GEV as "Buy", ETN as "Buy", UEC as "Buy", EMR as "Buy". Consensus price targets imply 27.1% upside for URG (target: $2) vs -4.9% for ETN (target: $380). For income investors, EMR offers the higher dividend yield at 1.49% vs ETN's 1.05%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $2.30 | $1119.95 | $379.78 | $18.67 | $161.92 |
| # AnalystsCovering analysts | 10 | 28 | 39 | 8 | 41 |
| Dividend YieldAnnual dividend ÷ price | — | +0.1% | +1.0% | — | +1.5% |
| Dividend StreakConsecutive years of raises | — | 1 | 24 | — | 37 |
| Dividend / ShareAnnual DPS | — | $1.00 | $4.17 | — | $2.10 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.2% | +1.2% | 0.0% | +1.6% |
EMR leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). GEV leads in 2 (Profitability & Efficiency, Total Returns).
URG vs GEV vs ETN vs UEC vs EMR: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is URG or GEV or ETN or UEC or EMR a better buy right now?
For growth investors, Uranium Energy Corp.
(UEC) is the stronger pick with 297. 4% revenue growth year-over-year, versus -19. 3% for Ur-Energy Inc. (URG). Emerson Electric Co. (EMR) offers the better valuation at 34. 9x trailing P/E (21. 7x forward), making it the more compelling value choice. Analysts rate Ur-Energy Inc. (URG) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — URG or GEV or ETN or UEC or EMR?
On trailing P/E, Emerson Electric Co.
(EMR) is the cheapest at 34. 9x versus GE Vernova Inc. at 59. 1x. On forward P/E, Emerson Electric Co. is actually cheaper at 21. 7x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Eaton Corporation plc wins at 1. 22x versus Emerson Electric Co. 's 4. 81x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — URG or GEV or ETN or UEC or EMR?
Over the past 5 years, GE Vernova Inc.
(GEV) delivered a total return of +698. 3%, compared to +29. 3% for Ur-Energy Inc. (URG). Over 10 years, the gap is even starker: UEC returned +1978% versus EMR's +206. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — URG or GEV or ETN or UEC or EMR?
By beta (market sensitivity over 5 years), Eaton Corporation plc (ETN) is the lower-risk stock at 1.
42β versus Uranium Energy Corp. 's 1. 79β — meaning UEC is approximately 26% more volatile than ETN relative to the S&P 500. On balance sheet safety, Uranium Energy Corp. (UEC) carries a lower debt/equity ratio of 0% versus 88% for Ur-Energy Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — URG or GEV or ETN or UEC or EMR?
By revenue growth (latest reported year), Uranium Energy Corp.
(UEC) is pulling ahead at 297. 4% versus -19. 3% for Ur-Energy Inc. (URG). On earnings-per-share growth, the picture is similar: GE Vernova Inc. grew EPS 217. 0% year-over-year, compared to -172. 1% for Uranium Energy Corp.. Over a 3-year CAGR, URG leads at 1027% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — URG or GEV or ETN or UEC or EMR?
Eaton Corporation plc (ETN) is the more profitable company, earning 14.
9% net margin versus -275. 3% for Ur-Energy Inc. — meaning it keeps 14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EMR leads at 19. 6% versus -255. 0% for URG. At the gross margin level — before operating expenses — EMR leads at 52. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is URG or GEV or ETN or UEC or EMR more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Eaton Corporation plc (ETN) is the more undervalued stock at a PEG of 1. 22x versus Emerson Electric Co. 's 4. 81x. A PEG below 1. 5 suggests fair-to-attractive pricing relative to expected growth. On forward earnings alone, Emerson Electric Co. (EMR) trades at 21. 7x forward P/E versus 37. 6x for GE Vernova Inc. — 15. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for URG: 27. 1% to $2. 30.
08Which pays a better dividend — URG or GEV or ETN or UEC or EMR?
In this comparison, EMR (1.
5% yield), ETN (1. 0% yield) pay a dividend. URG, GEV, UEC do not pay a meaningful dividend and should not be held primarily for income.
09Is URG or GEV or ETN or UEC or EMR better for a retirement portfolio?
For long-horizon retirement investors, Eaton Corporation plc (ETN) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (1.
0% yield, +608. 7% 10Y return). Ur-Energy Inc. (URG) carries a higher beta of 1. 52 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ETN: +608. 7%, URG: +258. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between URG and GEV and ETN and UEC and EMR?
These companies operate in different sectors (URG (Energy) and GEV (Utilities) and ETN (Industrials) and UEC (Energy) and EMR (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: URG is a small-cap quality compounder stock; GEV is a large-cap quality compounder stock; ETN is a mid-cap quality compounder stock; UEC is a small-cap high-growth stock; EMR is a mid-cap quality compounder stock. ETN, EMR pay a dividend while URG, GEV, UEC do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.